Clinical Evaluation of the V5-LU01 AI Software in Thoracic CT for V5med Inc.

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 18, 2023

Primary Completion Date

May 17, 2024

Study Completion Date

May 17, 2024

Conditions
Lung Cancer
Interventions
DEVICE

V5med Lung AI

"During the second reading session (concurrent read), the radiologist will be presented with a standard appearing CT with CADe marks placed on the left window and the same original without any AI mark with be display on the right window. Deeming a nodule, the radiologist will mark location. These may or may not correspond to the locations of the CADe markers. As in the baseline study, the radiologist will assign a level of suspicious to each mark and provide a Lung-RADS score and the size of longest dimension."

Trial Locations (1)

22203

Arlington Innovation Center: Health Research, Arlington

All Listed Sponsors
lead

V5med Inc.

INDUSTRY

NCT06514248 - Clinical Evaluation of the V5-LU01 AI Software in Thoracic CT for V5med Inc. | Biotech Hunter | Biotech Hunter